Astron
Astron Corporation Limited is an ASX-listed mineral sands and rare earth developer advancing the Donald Rare Earth and Mineral Sands Project in Victoria, Australia, with first production targeted for H2 2027 and downstream off-take via Energy Fuels Inc.
- Company typePublic
- Founded1956
- HeadquartersRatmalana, Sri Lanka
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Astron does
Astron Corporation Limited is an ASX-listed mineral sands and rare earth developer whose flagship asset is the Donald Rare Earth and Mineral Sands Project in Victoria, Australia. The project is designed to produce a basket of critical and strategic minerals — rare earth elements, zircon, titanium minerals, and tin/tungsten — targeting first production in H2 2027, and is positioned to supply US and allied critical-mineral supply chains as an alternative to Chinese-dominated rare-earth processing. The company is backed by a strategic partnership with US-listed Energy Fuels Inc. for downstream processing and off-take, which Astron partially monetised via the November 2025 sale of 686,974 Energy Fuels shares for approximately $9.8 million. In October 2025, Astron secured a Conditional Letter of Support from Export Finance Australia for up to A$80 million in project financing for the Donald Project. The company retains legacy exploration/development interests outside Australia (notably in China and Senegal), but the consolidated strategic focus has clearly shifted toward the Donald Project as the centre-of-gravity asset.
Note on data quality: the firmographic block in the input describes a Sri Lankan pharmaceutical company founded in 1956 (Astron Limited, Ratmalana). This is treated as a data-source conflation; every other supplied block — and all source IDs with recent operational context — describe the Australian mineral sands and rare earth developer Astron Corporation Limited. The above description follows the preponderance of source evidence.
The business model is that of a pre-revenue resource developer: the company monetises by developing mineral assets to production, then selling mineral concentrate (likely via the Energy Fuels off-take channel) into industrial and critical-minerals markets. Revenue mechanics will depend on offtake pricing structures (concentrate pricing, toll-processing fees, or royalty arrangements with downstream processors), none of which are publicly disclosed at this stage. Customer segments are industrial — rare-earth processors, zircon/titanium end-users, and strategic mineral buyers in defence and clean-tech supply chains — rather than consumer-facing.
Astron firmographics
Firmographics- Name
- Astron
- Legal name
- Astron Corporation Limited
- Website
- https://astron.lk
- Company type
- Public
- Founded year
- 1956
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Astron Corporation Limited is an ASX-listed mineral sands and rare earth developer advancing the Donald Rare Earth and Mineral Sands Project in Victoria, Australia, with first production targeted for H2 2027 and downstream off-take via Energy Fuels Inc.
- Ownership category
- akta.pro rank
Where Astron is headquartered
LocationHeadquarters
- HQ city
- Ratmalana
- HQ country
- Sri Lanka
- HQ region
- Asia
Markets served
Astron business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Astron product offering
Product offeringCore offering
Astron Limited develops, manufactures, imports, and markets pharmaceuticals and nutritional supplements. The company is headquartered in Ratmalana, Sri Lanka, was founded in 1956, and operates with 251–500 employees as a privately held, for-profit pharmaceutical company.
Product overview
Astron Corporation Limited is a diversified mining company engaged in mineral sands and rare earth projects across Australia, China, and Senegal. The company's primary focus is the Donald Rare Earth and Mineral Sands Project in Australia, which is positioned as a major initiative for producing critical rare earth elements. The company also holds interests in US critical minerals operations through its investment in Energy Fuels Inc.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical products Pharmaceutical drug products developed and manufactured by Astron Limited for the Sri Lankan market. The company develops and manufactures these products domestically and also imports pharmaceutical offerings, marketing them through healthcare distribution channels. Specific named products are not detailed in the available source data.
- Nutritional supplements Nutritional supplement products developed, manufactured, imported, and marketed by Astron Limited for the Sri Lankan market. Specific named supplement products or brands are not detailed in the available source data.
Quantifiable outcome
- Production planned to start as early as H2 2027
Companies that use Astron
Customer profileIdeal customer profiles1 record
Astron technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Astron partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Energy Fuels Inc.coreAstron and Energy Fuels are collaborating on the Donald Rare Earth and Mineral Sands Project in Australia. Energy Fuels is a US company involved in uranium mining, and Astron divested 686,974 shares of Energy Fuels Inc. for $9.8 million.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Astron competitors and assessment
Company assessmentBroad incumbents
- Tronox Holdings: Global mineral sands producer with vertically integrated zircon and titanium dioxide operations. Comparable as a major incumbent in the mineral sands sector where Astron's Donald project sits.
- MP Materials: Largest US rare earth producer and miner (Mountain Pass). Comparable as a Western-aligned rare earth producer benefiting from US critical minerals policy, though larger and further along the development curve.
Emerging players
- Vital Metals: Australian-listed rare earth developer focused on the Nechalacho project in Canada. Comparable as a small-cap rare earth developer with a multi-jurisdictional project portfolio.
- Ionic Rare Earths: Australian rare earth and critical minerals developer with processing technology focus (magnet recycling and rare earth refining). Comparable as a smaller-scale rare earth company pursuing Western downstream integration.
- Peak Resources: Australian rare earth developer with the Ngualla project in Tanzania. Comparable as a smaller rare earth developer with African jurisdictional exposure analogous to Astron's Senegal footprint.
Direct peers
- Iluka Resources: Australian mineral sands producer with rare earth credits from monazite processing. Closely comparable to Astron as a domestic mineral sands operator with rare earth by-product exposure and government-supported project financing history.
- Lynas Rare Earths: Australia's largest rare earth producer (Mt Weld), operating in mineral sands-adjacent geology with established processing and downstream offtake. Directly comparable as an Australian rare earth miner targeting Western supply chain security.
- Image Resources: Australian mineral sands producer operating the Boonanarring and Atlas projects in Western Australia. Comparable as a smaller Australian mineral sands operator with similar geography to Astron's Donald project.
- Energy Fuels Inc. US-based uranium and critical minerals producer with rare earth processing capabilities. Direct peer via the Donald project co-development partnership and overlapping focus on Western-aligned critical minerals supply chains.
- Arafura Rare Earths: Australian rare earth developer focused on the Nolans NdPr project. Directly comparable as an ASX-listed pre-production rare earth developer targeting downstream magnet supply chains.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Astron social profiles
Digital presenceAstron financial estimates
Financial estimateRevenue estimate
Valuation estimate
Astron leadership team
Management profileNumber of profiles
Astron funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Astron M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Astron
What does Astron do?
Astron Limited develops, manufactures, imports, and markets pharmaceuticals and nutritional supplements. The company is headquartered in Ratmalana, Sri Lanka, was founded in 1956, and operates with 251–500 employees as a privately held, for-profit pharmaceutical company.
Is Astron a public or private company?
Astron is a public company. It is classified as unknown and is currently operating.
When was Astron founded?
Astron was founded in 1956. It employs 251 to 500 people.
Where is Astron based?
Astron is headquartered in Ratmalana, Sri Lanka, in the Asia region.
Who are Astron's main competitors?
Broad incumbents on record are Tronox Holdings and MP Materials. Emerging players are Vital Metals, Ionic Rare Earths and Peak Resources. Direct peers are Iluka Resources, Lynas Rare Earths, Image Resources, Energy Fuels Inc. and Arafura Rare Earths.
Does Astron have an API?
No public API is recorded for Astron.